Finance

Lists
KROS:NASDAQ
Keros Therapeutics Inc
၁၁.၂၆ US$
-၁.၂၃%
(-၀.၁၄) 1D
၁၁.၂၆ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
၁၁.၃၈ US$
High
၁၁.၄၄ US$
Low
၁၁.၀၈ US$
Mkt. cap
၂၂.၃၃ ကုဋေ
Avg. vol.
၁.၈၁ သိန်း
Volume
၀.၀၀
52-wk high
၂၂.၅၅ US$
52-wk low
၉.၆၉ US$
EPS
-၃.၇၀ US$
Beta
၁.၀၁
Shares outstanding
၁.၉၈ ကုဋေ
No. of employees
၉၂
Open
၁၁.၃၈ US$
High
၁၁.၄၄ US$
Low
၁၁.၀၈ US$
Mkt. cap
၂၂.၃၃ ကုဋေ
Avg. vol.
၁.၈၁ သိန်း
Volume
၀.၀၀
52-wk high
၂၂.၅၅ US$
52-wk low
၉.၆၉ US$
EPS
-၃.၇၀ US$
Beta
၁.၀၁
Shares outstanding
၁.၉၈ ကုဋေ
No. of employees
၉၂
News stories
From web sources and news partners
The Dark Side Of The Boom
The Dark Side Of The Boom
·
ပြီးခဲ့သည့် ၆ မိနစ်
Citadel Securities’ Rubner Sees Retail Cash Reloading on Stocks
WSYR
WSYR
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Asian shares mixed after global bond sell-off deepens and ahead of US jobs data
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၉ မိနစ်
Mvb Financial (NASDAQ:MVBF) Stock Jumps 2.5% - Should You Buy?
Reuters
Reuters
·
ပြီးခဲ့သည့် ၅ နာရီ
Moderna to replace Warner Bros Discovery on Nasdaq 100
About Keros Therapeutics Inc
CEO-
Employees၉၂
Founded၂၀၁၅
HeadquartersLexington, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
3
Hold
3
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current ၁၁.၂၆ US$
၂၃.၀၀ US$ (+၁၀၄.၂၆%)
Average
၁၈.၈၀ US$ (+၆၆.၉၆%)
Lowest
၁၆.၀၀ US$ (+၄၂.၁၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Benjamin Burnett
Wells Fargo
Buy
Maintained
၁၈.၀၀ US$
+၅၉.၉%
09/02/2026
Jason Zemansky
Bank of America Securities
Hold
Reiterated
၁၇.၀၀ US$
+၅၁%
08/11/2026
Yun Zhong
Wedbush
Hold
Maintained
၁၆.၀၀ US$
+၄၂.၁%
08/04/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
၂၀.၀၀ US$
+၇၇.၆%
08/04/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
၂၃.၀၀ US$
+၁၀၄.၃%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
၂၇.၀၀ US$
+၁၃၉.၈%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
၃၀.၀၀ US$
+၁၆၆.၄%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
၂၀.၀၀ US$
+၇၇.၆%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၄၃ ကုဋေ
၃.၈၅ သိန်း
၃.၆၇ သိန်း
-
Cost of goods sold
၁.၉၅ ကုဋေ
၁.၇၈ ကုဋေ
၁.၆၁ ကုဋေ
၂.၂၃ ကုဋေ
Cost of revenue
၁.၉၅ ကုဋေ
၁.၇၈ ကုဋေ
၁.၆၁ ကုဋေ
၂.၂၃ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၁ ကုဋေ
၁.၁၇ ကုဋေ
၁.၀၁ ကုဋေ
၈.၆၁ သန်း
Operating expense
၁.၀၁ ကုဋေ
၁.၁၇ ကုဋေ
၁.၀၁ ကုဋေ
၈.၆၁ သန်း
Total operating expenses
၂.၉၆ ကုဋေ
၂.၉၆ ကုဋေ
၂.၆၂ ကုဋေ
၃.၀၉ ကုဋေ
Operating income
-၁.၅၄ ကုဋေ
-၂.၉၂ ကုဋေ
-၂.၅၉ ကုဋေ
-၃.၀၉ ကုဋေ
Other non operating income
-
-၅.၃၉ သိန်း
-
-၆.၀၀ သောင်း
EBT including unusual items
-၈.၇၀ သန်း
-၂.၅၀ ကုဋေ
-၂.၃၇ ကုဋေ
-၂.၈၇ ကုဋေ
EBT excluding unusual items
-၈.၇၀ သန်း
-၂.၄၉ ကုဋေ
-၂.၃၇ ကုဋေ
-၂.၈၇ ကုဋေ
Income tax expense
-၁.၄၂ သန်း
-၁.၅၁ သန်း
-
-
Effective tax rate
၁၆.၃၆%
၆.၀၆%
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၂၈ သန်း
-၂.၃၅ ကုဋေ
-၂.၃၇ ကုဋေ
-၂.၈၇ ကုဋေ
Net profit margin
-၅၁.၀၄%
-၆,၀၉၃.၇၇%
-၆,၄၅၉.၉၅%
-
Earnings per share
-၀.၁၈
-၀.၈၆
-၁.၂၁
-၁.၄၅
Interest and investment income
၆.၉၃ သန်း
၄.၀၂ သန်း
၂.၃၄ သန်း
၂.၂၉ သန်း
Interest expense
-
-
-
-
Net interest expenses
၆.၉၃ သန်း
၄.၀၂ သန်း
၂.၃၄ သန်း
၂.၂၉ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၅၀ ကုဋေ
-၂.၈၈ ကုဋေ
-၂.၅၅ ကုဋေ
-၃.၀၅ ကုဋေ
Gain or loss from assets sale
-
၁.၀၀ ထောင်
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ